title: Role of vagal innervation on pulmonary surfactant system during fetal development.
abstract: Vagally mediated afferent feedback and compliant lungs (surfactant system) play vital roles in the establishment of adequate alveolar ventilation and pulmonary gas exchange at birth. Although the significance of vagal innervation in the establishment of normal breathing patterns is well recognized, the precise role of lung innervation in the maturation of the surfactant system remains unclear. The specific aim of the present study was to investigate whether vagal denervation compromises the surfactant system during fetal development. Experiments were performed on 12 time-dated fetal sheep: 8 underwent cervical vagal denervation, and 4 were sham operated. Vagal denervation was performed at 110-113 days gestation. Fetal lambs were instrumented in utero to record arterial pH and blood-gas tensions. The animals were delivered by cesarean section under general anesthesia between 130 and 133 days gestation (term approximately 147 days). Lung samples were collected for wet-to-dry ratios, light and electron microscopy, and overall lung morphology. In addition, total proteins, total phospholipids, and surfactant proteins A and B were analyzed in both lung tissue and bronchoalveolar lavage fluid. Vagal denervation had no effect on alveolar architecture, including type II cells or the morphology of lamellar bodies within them. Furthermore, surfactant proteins A and B and total phospholipids were similar in lung tissue and bronchoalveolar lavage fluid between the two groups. A significant correlation was observed between circulating cortisol concentrations and surfactant proteins in the bronchoalveolar lavage fluid and lung tissue. We provide definitive evidence that vagal innervation at midgestation is not required for maturation of the pulmonary surfactant system during fetal development.
authors.affiliation: Dept. of Pediatrics, Health Sciences Center, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1.
authors.forename: Luxmi
authors.initials: L
authors.lastname: Gahlot
authors.forename: Francis H Y
authors.initials: FH
authors.lastname: Green
authors.forename: Anita
authors.initials: A
authors.lastname: Rigaux
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Schneider
authors.forename: Shabih U
authors.initials: SU
authors.lastname: Hasan
mesh_terms: D000818:Animals; D001784:Blood Gas Analysis; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D003714:Denervation; D047109:Fetal Development / Q000502:physiology*; D005865:Gestational Age; D006863:Hydrogen-Ion Concentration; D008168:Lung / Q000294:innervation* / Q000378:metabolism / Q000648:ultrastructure; D010743:Phospholipids / Q000378:metabolism; D037662:Pulmonary Surfactant-Associated Protein A / Q000032:analysis / Q000378:metabolism; D037701:Pulmonary Surfactant-Associated Protein B / Q000032:analysis / Q000378:metabolism; D037661:Pulmonary Surfactant-Associated Proteins / Q000032:analysis / Q000378:metabolism*; D011663:Pulmonary Surfactants / Q000032:analysis / Q000378:metabolism*; D012756:Sheep; D014630:Vagus Nerve / Q000196:embryology* / Q000502:physiology* / Q000601:surgery
chemical_list: D010743:Phospholipids; D037662:Pulmonary Surfactant-Associated Protein A; D037701:Pulmonary Surfactant-Associated Protein B; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants